Constitutively active Stat3 signaling leads to the upregulation of many downstream target genes in ABC-DLBCL, and our data indicate that Fbw7 could inhibit the expression of these genes through degradation of activated Stat3. The gene discussed is STAT3; the disease is diffuse large B-cell lymphoma.